What is a stock summary page? Click here for an overview.
Business Description
Pharmigene Inc
ISIN : TW0007595B13
Share Class Description:
ROCO:7595: Ordinary SharesDescription
Pharmigene Inc is engaged in the development and sales of pharmaceutical genetic diagnostic products. Also, the company provides medical and drug testing services and equipment.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.26 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 1.77 | |||||
| Debt-to-EBITDA | -13.19 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.34 | |||||
| Beneish M-Score | -3.44 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -8.1 | |||||
| 3-Year EBITDA Growth Rate | -69.5 | |||||
| 3-Year EPS without NRI Growth Rate | -40.1 | |||||
| 3-Year FCF Growth Rate | -36.3 | |||||
| 3-Year Book Growth Rate | -7.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 6.66 | |||||
| 9-Day RSI | 13.32 | |||||
| 14-Day RSI | 19.06 | |||||
| 3-1 Month Momentum % | -9.09 | |||||
| 6-1 Month Momentum % | -15.58 | |||||
| 12-1 Month Momentum % | -33.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.77 | |||||
| Quick Ratio | 3.74 | |||||
| Cash Ratio | 3.06 | |||||
| Days Inventory | 183.74 | |||||
| Days Sales Outstanding | 61.36 | |||||
| Days Payable | 46.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.1 | |||||
| Shareholder Yield % | -6.24 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 35.59 | |||||
| Operating Margin % | -69.75 | |||||
| Net Margin % | -71.11 | |||||
| FCF Margin % | -95.94 | |||||
| ROE % | -21 | |||||
| ROA % | -8.08 | |||||
| ROIC % | -9.74 | |||||
| 3-Year ROIIC % | -8.9 | |||||
| ROC (Joel Greenblatt) % | -11.29 | |||||
| ROCE % | -7.19 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.14 | |||||
| PB Ratio | 1.72 | |||||
| Price-to-Tangible-Book | 1.54 | |||||
| EV-to-EBIT | -13.76 | |||||
| EV-to-EBITDA | -20.81 | |||||
| EV-to-Revenue | 8.34 | |||||
| EV-to-FCF | -9.67 | |||||
| Price-to-GF-Value | 0.68 | |||||
| Earnings Yield (Greenblatt) % | -7.26 | |||||
| FCF Yield % | -21.62 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharmigene Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 116.534 | ||
| EPS (TTM) (NT$) | -1.64 | ||
| Beta | 0.69 | ||
| 3-Year Sharpe Ratio | -0.44 | ||
| 3-Year Sortino Ratio | -0.72 | ||
| Volatility % | 17.22 | ||
| 14-Day RSI | 19.06 | ||
| 14-Day ATR (NT$) | 0.462641 | ||
| 20-Day SMA (NT$) | 12.2225 | ||
| 12-1 Month Momentum % | -33.67 | ||
| 52-Week Range (NT$) | 9.88 - 19.9 | ||
| Shares Outstanding (Mil) | 50.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharmigene Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharmigene Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharmigene Inc Frequently Asked Questions
What is Pharmigene Inc(ROCO:7595)'s stock price today?
The current price of ROCO:7595 is NT$10.25. The 52 week high of ROCO:7595 is NT$19.90 and 52 week low is NT$9.88.
When is next earnings date of Pharmigene Inc(ROCO:7595)?
The next earnings date of Pharmigene Inc(ROCO:7595) is .
Does Pharmigene Inc(ROCO:7595) pay dividends? If so, how much?
Pharmigene Inc(ROCO:7595) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers